The newest research report global Coronary Stents Market illustrates pin point sharp market insights includes detailed Coronary Stents industry aspects forecast over a period from 2018 to 2025. It conducts a fervent study of business positions to offer in detail knowledge of Coronary Stents business habits of past, present, and future.

The coronary stents market is estimated to grow at a CAGR of 7.8% during the forecast period from 2018 to 2025. The market for coronary stents is estimated to reach US$ 13,879.0 Mn by 2025. The market for coronary stents has been witnessing a healthy growth rate during the previous years and is expected to witness similar trend in the coming years. The coronary stents market is subject to strict and mandated regulatory policies. The companies operating in the market follow stringent regulations of the manufacturing guidelines. In addition, these manufacturing companies are focusing to invest in R&D to develop advanced products for end users such as, hospitals, ambulatory surgical centers, and the cardiac centers, among others.

The Coronary Stents market is anticipated to grow at a CAGR of 7.8% and reach US$ 13.88 Bn by 2025

Request Sample Copy of Coronary stents Market @ http://www.theinsightpartners.com/sample/TIPHE100000827#utm_source=sy

This report focuses on the top players in global market, like

1. Microport Scientific Corporation 
2. Translumina GmbH 
3. Abbott Laboratories 
4. Terumo Corporation 
5. Medtronic 
6. Biosensors International Groups, LTD 
7. Stentys SA 
8. Vascular Concepts 
9. B. Braun Melsungen AG 
10. Biotronik SE & CO. KG

The market for coronary stents is well established in North America region, especially in the U.S and Canada. Rising prevalence of various types of cardiac diseases and subsequent usage of coronary stents to treat these diseases is one of the major factors for the growth of coronary stents market in the country. According to the American Heart Association (AHA), in 2016, nearly 15.5 million persons aged above 20 years in the US have coronary heart diseases (CHD). The rising number of the coronary heart diseases need more number of coronary stents, hence, the coronary stents market is likely to grow during the forecast period.

Coronary stents are narrow expandable tubes, which are used to treat coronary diseases such as, artery blockage. These stents are used to perform angioplasty to keep the arteries open in the treatment of coronary artery disease. Coronary stents are usually made up of metal mesh, which acts against corrosion and helps to prevent the artery from recoiling or blocking again.

In our study, we have segmented the coronary stents market by type, absorption rate, material and end-users. The coronary stents by type is segmented as biodegradable stents, bare metal stents and drug eluting stents. The absorption rate segment was further segmented as the slow absorption rate and fast absorption rate. The coronary stents market, by material can be categorized as nitinol, polymers, nickel, gold, tantalum, stainless steel and cobalt alloy metal stents. The end user segment can be segmented into ambulatory surgical centers, hospitals and cardiac centers. Geographically, the market for coronary stents was categorized as North America, Europe, Asia Pacific (APC), Middle East and Africa (MEA) and South and Central America (S&CAM).

The major players operating in the market of coronary stents market include Microport Scientific Corporation, Medtronic PLC, Biosensors International Group, Ltd., Abbott Laboratories, Vascular Concepts Limited, Biotronik SE & Co. Kg, Stentys SA, B. Braun Melsungen AG, Translumina GmbH, and Terumo Corporation.

Else place an Inquire before Purchase “Global Coronary stents Market Size, Status and Forecast 2025 “@ http://www.theinsightpartners.com/inquiry/TIPHE100000827#utm_source=sy

(Note: If you have any special requirements, please let us know and we will offer you the report as you want.)

Posted by on Thursday June 14 2018, 5:15 PM EDT. All trademarks acknowledged. Filed under Featured Press Release, Healthcare, Life Sciences, Medical Devices. Comments and Trackbacks closed. Follow responses: RSS 2.0

Comments are closed

News Categories

Featured Press Releases

Latest News

Log in